Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 47 Records) |
| Query Trace: Breast Neoplasms and TAM[original query] |
|---|
| Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer. Breast cancer research and treatment 2014 Dec 148 (3): 571-80. Rangel Leticia B A, Taraba Jodi L, Frei Christopher R, Smith Lon, Rodriguez Gladys, Kuhn John |
| Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS one 2015 10 (7): e0132269. Romero-Lorca Alicia, Novillo Apolonia, Gaibar María, Bandrés Fernando, Fernández-Santander A |
| Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms and overall survival of breast cancer patients after tamoxifen therapy. Medical science monitor : international medical journal of experimental and clinical research 2015 21 563-9. Zhang Xuefeng, Pu Zhichen, Ge Jun, Shen Jie, Yuan Xiaolong, Xie Haita |
| Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment. Breast cancer (Dove Medical Press) 2016 8 149-55. Charoenchokthavee Wanaporn, Panomvana Duangchit, Sriuranpong Virote, Areepium Nuttha |
| Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics 2016 Apr . Sutiman Natalia, Lim Joanne Siok Liu, Muerdter Thomas E, Singh Onkar, Cheung Yin Bun, Ng Raymond Chee Hui, Yap Yoon Sim, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Schroth Werner, Schwab Matthias, Khor Chiea Chuen, Chowbay Balr |
| Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen. Frontiers in pharmacology 2017 8 582. Schroth Werner, Winter Stefan, Mürdter Thomas, Schaeffeler Elke, Eccles Diana, Eccles Bryony, Chowbay Balram, Khor Chiea C, Tfayli Arafat, Zgheib Nathalie K, Eichelbaum Michel, Schwab Matthias, Brauch Hiltr |
| Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients. Breast cancer (Dove Medical Press) 2017 9 249-256. Charoenchokthavee Wanaporn, Areepium Nutthada, Panomvana Duangchit, Sriuranpong Viro |
| The prognostic effects of somatic mutations in ER-positive breast cancer. Nature communications 2018 Sep 9 (1): 3476. Griffith Obi L, Spies Nicholas C, Anurag Meenakshi, Griffith Malachi, Luo Jingqin, Tu Dongsheng, Yeo Belinda, Kunisaki Jason, Miller Christopher A, Krysiak Kilannin, Hundal Jasreet, Ainscough Benjamin J, Skidmore Zachary L, Campbell Katie, Kumar Runjun, Fronick Catrina, Cook Lisa, Snider Jacqueline E, Davies Sherri, Kavuri Shyam M, Chang Eric C, Magrini Vincent, Larson David E, Fulton Robert S, Liu Shuzhen, Leung Samuel, Voduc David, Bose Ron, Dowsett Mitch, Wilson Richard K, Nielsen Torsten O, Mardis Elaine R, Ellis Matthew |
| Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China. International journal of cancer 2018 Jul . Lan Bo, Ma Fei, Chen Shanshan, Wang Wenna, Li Qiao, Fan Ying, Luo Yang, Cai Ruigang, Wang Jiayu, Yuan Peng, Zhang Pin, Li Qing, Xu Bing |
| Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer. Oncotarget 2018 May 9 (36): 24272-24282. Bednarczyk Robert B, Tuli Neha Y, Hanly Elyse K, Rahoma Ghada Ben, Maniyar Rachana, Mittelman Abraham, Geliebter Jan, Tiwari Raj |
| The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population. International journal of cancer 2018 07 143 (1): 184-189. Lan Bo, Ma Fei, Zhai Xiaoyu, Li Qiao, Chen Shanshan, Wang Jiayu, Fan Ying, Luo Yang, Cai Ruigang, Yuan Peng, Zhang Pin, Li Qing, Xu Bing |
| Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy. Asian Pacific journal of cancer prevention : APJCP 2018 Feb 19 (2): 343-350. Thota Kanakaiah, Prasad K, Basaveswara Rao Mandava |
| Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis. Cancer chemotherapy and pharmacology 2019 Jan 83 (1): 71-79. Bai Yu, Wu Hai-Wei, Zhang Yan-H |
| CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 2019 9 11 (9): . Ahmed Jemal Hussien, Makonnen Eyasu, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Aklillu Ele |
| Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy? Breast (Edinburgh, Scotland) 2019 5 46 52-57. Lee Clara I, Fox Peter, Balakrishnar Bavanthi, Balleine Rosemary L, Gao Bo, Provan Pamela, Coulter Sally, Liddle Christopher, Hui Rina, Wong Mark, Gurney Howard, Wilcken Nichol |
| 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor ?-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion. Breast cancer research and treatment 2019 4 175 (3): 567-578. Wang Gen, Qin Sisi, Zayas Jacqueline, Ingle James N, Liu Mohan, Weinshilboum Richard M, Shen Kunwei, Wang Liew |
| The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China. Clinical breast cancer 2018 Dec . Lan Bo, Ma Fei, Han Mei, Chen Shanshan, Wang Wenna, Li Qiao, Fan Ying, Luo Yang, Cai Ruigang, Wang Jiayu, Yuan Peng, Zhang Pin, Li Qing, Xu Bing |
| ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast cancer research : BCR 2020 Feb 22 (1): 16. Zundelevich Adi, Dadiani Maya, Kahana-Edwin Smadar, Itay Amit, Sella Tal, Gadot Moran, Cesarkas Karen, Farage-Barhom Sarit, Saar Efrat Glick, Eyal Eran, Kol Nitzan, Pavlovski Anya, Balint-Lahat Nora, Dick-Necula Daniela, Barshack Iris, Kaufman Bella, Gal-Yam Einav Ni |
| Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
| Synthesis of novel flexible tamoxifen analogues to overcome CYP2D6 polymorphism and their biological evaluation on MCF-7 cell line. Drug development research 2020 1 81 (4): 444-455. Ahmed Nermin S, Wober Jannet |
| Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics. Frontiers in oncology 2021 12 11 738222. Pang Hui, Zhang Guoqiang, Yan Na, Lang Jidong, Liang Yuebin, Xu Xinyuan, Cui Yaowen, Wu Xueya, Li Xianjun, Shan Ming, Wang Xiaoqin, Meng Xiangzhi, Liu Jiaxiang, Tian Geng, Cai Li, Yuan Dawei, Wang X |
| Comparison of adverse drug reactions between tamoxifen and toremifene in breast cancer patients with different CYP2D6 genotypes: A propensity-score matched cohort study. International journal of cancer 2021 12 150 (10): 1664-1676. Zhou Weihang, Jiang Yiwei, Xu Yaqian, Wang Yaohui, Ma Xiaowei, Zhou Liheng, Lin Yanping, Wang Yan, Wu Ziping, Li Min, Yin Wenjin, Lu Jinso |
| Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
| Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness. PloS one 2022 8 17 (8): e0273044. Pe Kristine Cate S, Saetung Rattana, Yodsurang Varalee, Chaotham Chatchai, Suppipat Koramit, Chanvorachote Pithi, Tawinwung Supannik |
| Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ breast cancer 2022 Jul 8 (1): 88. Marczyk Michal, Qing Tao, O'Meara Tess, Yagahoobi Vesal, Pelekanou Vasiliki, Bai Yalai, Reisenbichler Emily, Cole Kimberly S, Li Xiaotong, Gunasekharan Vignesh, Ibrahim Eiman, Fanucci Kristina, Wei Wei, Rimm David L, Pusztai Lajos, Blenman Kim R |
| Flexible Etherified and Esterified Triphenylethylene Derivatives and Their Evaluation on ER-positive and Triple-Negative Breast Cancer Cell Lines. ChemMedChem 2022 Jan e202100720. Hassan Aya S, Wober Jannette, Vollmer Günter, Abadi Ashraf H, Ahmed Nermin |
| CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients. Experimental biology and medicine (Maywood, N.J.) 2023 9 15353702231187640. Muhammad Usman Tareen, Sana Riaz, Saima Shakil Malik, Sana Zahid, Anum Khursheed, Fizza Tariq, Faiza Abbas, Muhammad Nouman Malik, Riffat Aysha Anis, Mariam Anees, Iram Murtaza, Aneesa Sult |
| Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
| Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D6*17 Variant on the Formation of the Active Metabolite, Endoxifen. Journal of personalized medicine 2023 2 13 (2): . Kanji Comfort Ropafadzo, Nyabadza Georginah, Nhachi Charles, Masimirembwa Coll |
| Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis 2023 11 238 115839. Fatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, Mohammad Reza Shiran, Ehsan Zaboli, Seyed Mojtaba Sohrevardi, Tannaz Jamialahmadi, Adeleh Sahebnasagh, Amirhossein Sahebk |
- Page last reviewed:Feb 1, 2024
- Content source: